Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arrowhead Pharmaceuticals (ARWR) Other financing activities: 2010-2024

Historic Other financing activities for Arrowhead Pharmaceuticals (ARWR) over the last 3 years, with Dec 2024 value amounting to $5.0 million.

  • Arrowhead Pharmaceuticals' Other financing activities was N/A to $5.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.8 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2025, which is 59.54% up from last year.
  • According to the latest figures from Q4 2024, Arrowhead Pharmaceuticals' Other financing activities is $5.0 million, which was up 59.54% from $3.1 million recorded in Q3 2024.
  • Arrowhead Pharmaceuticals' Other financing activities' 5-year high stood at $5.0 million during Q4 2024, with a 5-year trough of $3.1 million in Q3 2024.
  • Moreover, its 1-year median value for Other financing activities was $4.1 million (2024), whereas its average is $4.1 million.